Api

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. It invests in, supports, and grows early-stage companies developing treatments in areas of high unmet medical need. The firm's team comprises leading advanced therapy scientists and experienced life science investors.

Afore Capital is a $300M fund investing in pre-traction companies. They focus on what can go right and work quickly to make decisions. They consider themselves a founder's SWAT team, providing support and asking tough questions.

ATX Venture Partners is an early-stage venture capital firm investing across North America, primarily in disruptive B2B software, APIs, marketplaces, and applications. They focus on providing capital and a value-add platform to help portfolio companies accelerate growth.

Bloomberg Beta invests at early stages in companies that improve business operations. They have published an open-source guide detailing their fund's operations.

Civilization Ventures is a venture capital firm investing in scientific founders focused on cutting-edge innovations in health tech and biology. They support founders with a "mentor capital" approach, leveraging their vast network of experienced biopharma executives. Their investments span genomics, diagnostics, digital health, and synthetic biology.

Clocktower Ventures is the technology investing arm of Clocktower Group, a global macro investment firm. They focus exclusively on financial technology, partnering with entrepreneurs reinventing financial services and addressing climate change.

Drive Capital is a venture capital firm that invests in founders building market-defining companies. They focus on opportunities east of the Rockies and west of the Hudson River, believing the best advantages are those entrepreneurs already possess. They are stage-agnostic, preferring to journey with their portfolio companies from start to finish.

Dynamk Capital invests in innovative tools and technologies that are critical for the discovery, development and production of life-saving therapies. We partner with life science visionaries whose market-defining ideas are shaping the future of how therapeutics are being developed, increasing access for patients, and reducing costs.

Earl Grey Capital is an early-stage venture fund focused on backing founders building internet infrastructure. They invest in companies focused on APIs, protocols, and developer infrastructure. Their investment philosophy centers on founders backing founders, leveraging their experience co-founding Clearbit.

Easo Ventures is a Basque and private Venture Capital firm that invests in startups and SMEs with growth projects. They offer investment, advice, and experience to entrepreneurs and SMEs looking to grow their businesses. Their investment strategy focuses on early-stage companies.

Fintech Ventures Fund is a venture capital firm hyperfocused on partnering with founders transforming legacy areas of financial services, particularly those with capital markets, lending, and insurance use cases. They are often the first institutional investors and prefer B2B or B2B2C business models.

Fontinalis Partners, LLC is an early-stage venture capital firm focused on mobility technologies. They invest in startups enabling efficient movement and horizontal enabling technologies, partnering with ambitious founders to build iconic companies.